| Literature DB >> 24800108 |
Debarati Chattopadhyay1, Ashok Somaiah1, Divya Raghunathan1, Kavitha Thirumurugan1.
Abstract
Nutraceutical compounds show antioxidant and prooxidant properties under stress conditions like cancer, diabetes, and other diseases. The objective of this study is to find the dichotomic behavior of caffeine, curcumin, and naringenin on DNA of diabetic and normal subjects in the presence and absence of copper, hydrogen peroxide, and complex of copper-hydrogen peroxide. Hydrogen peroxide releases hydroxyl free radicals ((•)OH) on oxidation of Cu (I) to Cu (II) through Fenton-type reaction to cause DNA damage. In the results, agarose gel electrophoretic pattern speculates the prooxidant effect of caffeine and antioxidant effect of curcumin on DNA in the presence of copper and hydrogen peroxide. UV-Vis spectral analysis shows hyperchromism on addition of DNA to caffeine, hypochromism with curcumin, and subtle changes with naringenin. The chosen nutraceuticals act as inducers and quenchers of oxidative free radicals arising from diabetes.Entities:
Year: 2014 PMID: 24800108 PMCID: PMC3985309 DOI: 10.1155/2014/649261
Source DB: PubMed Journal: Scientifica (Cairo) ISSN: 2090-908X
Clinical characteristics of studied subjects.
| Subjects | Postprandial blood glucose level (mg/dL) | Age | Smoking habits | Other symptoms |
|---|---|---|---|---|
| Patient 1 | 452 | 38 | Chain smoker | Delayed wound healing, boils, high blood pressure (140/100) |
| Patient 2 | 379 | 55 | Nonsmoker | Knee pain, poor eyesight |
| Patient 3 | 337 | 59 | Nonsmoker | Knee and back pain, numbness of feet |
| Patient 4 | 308 | 51 | Nonsmoker | None |
| Patient 5 | 411 | 50 | Nonsmoker | Poor eyesight, high blood pressure (150/90) |
| Patient 6 | 427 | 50 | Nonsmoker | Poor eye sight, boils |
All the patients were newly diagnosed with Type 2 Diabetes Mellitus. Therefore, none of the patients were on any drug administration and insulin treatment.
Figure 1Agarose gel electrophoresis (1.2%) of genomic DNA from nondiabetic human ((a), (b), (c)) and diabetic subject ((d), (e), (f)). L1: Genomic DNA (untreated, control, 15 μg). L2: DNA (15 μg) + H2O2 (4 mM). L3: DNA (15 μg) + CuSO4 (4 mM). L4: DNA (15 μg) + H2O2 (4 mM) + CuSO4 (4 mM). L5: DNA (15 μg) + H2O2 (50 μM) + *Phytocompound (50 μM) + CuSO4 (50 μM). L6: DNA (15 μg) + H2O2 (500 μM) + *Phytocompound (500 μM) + CuSO4 (500 μM). L7: DNA (15 μg) + H2O2 (1 mM) + *Phytocompound (1 mM) + CuSO4 (1 mM). L8: DNA (15 μg) + H2O2 (2 mM) + *Phytocompound (2 mM) + CuSO4 (2 mM). L9: DNA (15 μg) + H2O2 (4 mM) + *Phytocompound (4 mM) + CuSO4 (4 mM). L10: DNA (15 μg) + H2O2 (6 mM) + *Phytocompound (6 mM) + CuSO4 (6 mM). *Caffeine, curcumin, and naringenin.
Figure 2Spectra of caffeine, curcumin, and naringenin with DNA from nondiabetic ((a), (b), (c)) and diabetic subject ((d), (e), (f)) in the presence and absence of copper.